Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study

BACKGROUND: COVID-19 characterized by refractory hypoxemia increases patient mortality because of immunosuppression effects. This study aimed to evaluate the efficacy of immunomodulatory with thymosin α1 for critical COVID-19 patients. METHODS: This multicenter retrospective cohort study was perform...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int Immunopharmacol
Main Authors: Wu, Ming, Ji, Jing-jing, Zhong, Li, Shao, Zi-yun, Xie, Qi-feng, Liu, Zhe-ying, Wang, Cong-lin, Su, Lei, Feng, Yong-wen, Liu, Zhi-feng, Yao, Yong-ming
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier B.V. 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409727/
https://ncbi.nlm.nih.gov/pubmed/32795897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106873
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker